ATE447396T1
Gel comprising tenofovir or tenofovir disoproxil
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 1 July 2025, 1.2 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
59 members in 30 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 58683904 | United States of America | P | |
| 2005023492 | United States of America | W |
Members59
| Document | Office | Kind | |
|---|---|---|---|
| AU2005272032A1 | Australia | A1 | |
| CA2570877A1 | Canada | A1 | |
| WO2006017044A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2006058265A1 | United States of America | A1 | |
| TW200612955A | Taiwan Province of China | A | |
| WO2006017044A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AR050424A1 | Argentina | A1 | |
| IS8584A | Iceland | A | |
| NO20070762L | Norway | L | |
| AP2007003873A0 | African Regional Intellectual Property Organization (ARIPO) | A0 | |
| EP1773296A2 | European Patent Office (EPO) | A2 | |
| KR20070041537A | Republic of Korea | A | |
| HRP20070040A2 | Croatia | A2 | |
| MX2007000122A | Mexico | A | |
| IL180172A0 | Israel | A0 | |
| CN1984640A | China | A | |
| EA200700311A1 | Eurasian Patent Organization (EAPO) | A1 | |
| PL382306A1 | Poland | A1 | |
| HK1103026A | Hong Kong, China | A | |
| HK1103026A1 | Hong Kong, China | A1 | |
| US2008035155A1 | United States of America | A1 | |
| JP2008505902A | Japan | A | |
| BRPI0513196A | Brazil | A | |
| ZA200700932B | South Africa | B | |
| EP1773296B1 | European Patent Office (EPO) | B1 | |
| AT447396T | Austria | T | |
| ATE447396T1This record | Austria | T1 | |
| DE602005017497D1 | Germany | D1 | |
| EP2138162A2 | European Patent Office (EPO) | A2 | |
| EP2138163A2 | European Patent Office (EPO) | A2 | |
| PT1773296E | Portugal | E | |
| HRP20100038T1 | Croatia | T1 | |
| DK1773296T3 | Denmark | T3 | |
| ES2336017T3 | Spain | T3 | |
| PL1773296T3 | Poland | T3 | |
| SI1773296T1 | Slovenia | T1 | |
| CN1984640B | China | B | |
| NZ552172A | New Zealand | A | |
| IL206031A0 | Israel | A0 | |
| RS51213B | Serbia | B | |
| UA93354C2 | Ukraine | C2 | |
| EP2283812A2 | European Patent Office (EPO) | A2 | |
| US2011120475A1 | United States of America | A1 | |
| US2011132376A1 | United States of America | A1 | |
| AU2005272032B2 | Australia | B2 | |
| EP2138162A3 | European Patent Office (EPO) | A3 | |
| EP2138163A3 | European Patent Office (EPO) | A3 | |
| EP2283812A3 | European Patent Office (EPO) | A3 | |
| IL180172A | Israel | A | |
| JP2012255021A | Japan | A | |
| JP5121451B2 | Japan | B2 | |
| KR101225707B1 | Republic of Korea | B1 | |
| EA017763B1 | Eurasian Patent Organization (EAPO) | B1 | |
| AP2666A | African Regional Intellectual Property Organization (ARIPO) | A | |
| CA2570877C | Canada | C | |
| EA201370001A1 | Eurasian Patent Organization (EAPO) | A1 | |
| US9060933B2 | United States of America | B2 | |
| US2015366795A1 | United States of America | A1 | |
| US9283182B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 5771562
Titles2
- German
- PHARMAZEUTISCHES VAGINALES GEL MIT TENOFOVIR
- English
- PHARMACEUTICAL VAGINAL GEL WITH TENOFOVIR
Classification
- CPC, 14
- A61K9/02
- A61K9/16
- A61K31/505
- A61K31/675
- A61F6/04
- A61K9/0014
- A61P15/00
- A61P31/00
- A61P31/12
- A61P31/18
- A61P43/00
- A61K9/48
- A61K9/12
- A61K9/0034